Therefore, it is suggested that SIgAD patients have defective regulation of the IgA response due to reduced Th1 and Th17 cells and increased blood concentrations of TGF-β1, BAFF and APRIL (137). The gene discussed is TNFSF13; the disease is selective IgA deficiency disease.